Barclays Wealth has unveiled a new version of its Emerging Markets Optimiser (EMO), a six-year investment offering exposure to 21 emerging markets.
The product is linked to the iShares MSCI Emerging Market index fund, tracking a range of emerging markets with heavy weighting to the BRIC countries. EMO pays out 70% of any positive performance of the underlying index. The six-year Optimiser, in its 12th issue, is backed by Barclays and promises full return of capital at maturity, irrespective of the performance of the underlying index. The product also employs a dynamic allocation strategy to minimize the impact of market fluctuations. Barclays Wealth vice president Lisa Chaudhuri says the product helps to mitigate volatility by...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes